X LSP acquired by EQT and renamed to EQT Life Sciences

On November 10, 2021, LSP announced that it will join forces with EQT AB (“EQT”), one of the largest private equity firms in Europe and among the top-ten private equity firms globally. The press release can be found here link. The closing of EQT’s acquisition of LSP took place on February 28, 2022. Henceforth, LSP will be called EQT Life Sciences.

EQT's acquisition of LSP is driven by the complementarity of investment expertise between the firms as well as significant growth opportunities and scale benefits. As part of EQT, LSP will be able to continue its strategy and operations as it has done successfully over the past years while leveraging the added value of being part of the EQT family.

René Kuijten, Managing Partner at LSP, and incoming Partner and Head of EQT Life Sciences, said, “Europe has many attractive life sciences companies. Together with EQT, one of the largest European private equity firms with more than EUR 73 billion in assets under management, LSP can select, develop, and finance these opportunities even better than before. Given the strong cultural fit and the complementarity between our organisations, we are convinced that joining forces is a win-win for our investors, our portfolio companies, our LSP colleagues, and the broader European life sciences ecosystem.”

For more information, please contact:
René R. Kuijten, MD PhD MBA
Partner, Head of EQT Life Sciences
rkuijten@lspvc.com